Financial Result Releases, Strategic Partnership, Shopping Festival Review, and Acquisition Updates - Analyst Notes on ARM, Interserve, Shaftesbury, Halma and Britvic

LONDON, June 9, 2014 /PRNewswire/ --

Today, Earnings Review released its analysts' notes regarding ARM Holdings plc (LON: ARM), Interserve plc (LON: IRV), Shaftesbury plc (LON: SHB), Halma plc (LON: HLMA) and Britvic Plc (LON: BVIC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://earnings-review.com/3475-100free.

--
ARM Holdings plc Analyst Notes
On April 23, 2014, ARM Holdings plc (ARM) released its Q1 2014 financial results. The Company reported Q1 2014 revenues of £186.7 million, up 9.6% YoY, helped by strong growth in technology licensing revenues and services revenues. During the quarter, the Company's operating profit improved 17.6% YoY to £76.3 million. The Company's Q1 2014 net profit came in at £62.3 million, or 4.4 pence per diluted share, compared to profit of £51.9 million, or 3.7 pence per diluted share, in Q1 2013. As on March 31, 2014, the Company's cash and cash equivalents were £39.0 million, compared to cash and cash equivalents of £43.8 million on December 31, 2013. The full analyst notes on ARM are available to download free of charge at:

http://earnings-review.com/3475-ARM-09Jun2014.pdf

--
Interserve plc Analyst Notes
On June 3, 2014, Interserve plc (Interserve) announced that the University Hospital Southampton NHS Foundation Trust (UHS) has selected the Company as its long term commercial estates development partner in a joint venture. Under the partnership, which is for up to 25 years and is worth around £150 million, Interserve and UHS will team up with health and social care property company Prime to secure funding for new development projects. The initial programme of projects that the partnership will undertake includes the construction of a new main entrance, a welcome centre, shops and a multi-storey car park, as well as an on-site hotel capable of accommodating at least 24 private patients undergoing tests or treatment at UHS. Adrian Ringrose, Interserve CEO, said, "Our partnership with Prime will benefit UHS patients and the staff who care for them as well as generating important additional income for the Trust." The full analyst notes on Interserve are available to download free of charge at:

http://earnings-review.com/3475-IRV-09Jun2014.pdf

--
Shaftesbury plc Analyst Notes
On May 17, 2014, Shaftesbury plc (Shaftesbury) announced that the Seven Dials and St Martin's Courtyard Spring Shopping Festival saw 30% increase in footfall versus the previous Saturday. Shaftesbury informed that more than 130 retailers, cafés and restaurants took part in the event. Commenting on the success of the debut Shopping Festival, Clare Harris, Head of Marketing Communications at Shaftesbury, said, "We are delighted with the success of our Shopping Festival, which saw Seven Dials become London's green heart for the day." The full analyst notes on Shaftesbury are available to download free of charge at:

http://earnings-review.com/3475-SHB-09Jun2014.pdf

--
Halma plc Analyst Notes
On May 30, 2014, Halma plc (Halma) announced that it has completed the acquisition of RCS, a company engaged in designing, manufacturing and selling of pipeline corrosion monitoring products and systems into diverse industries. Halma informed that it has paid £64.7 million ($108 million) as cash consideration to RCS's private shareholders, plus £4.8 million for cash retained in the business. RCS will join the Company's Process Safety sector, collaborating with businesses which already operate in the same industries with similar long-term market growth drivers, including increasing safety requirements. In addition, the Company completed the sale of Monitor Elevator Products, Inc. to Innovation Industries Inc. for a cash consideration of £3.6 million ($6.0 million) which was paid at completion, of which £0.5 million ($0.9 million) was retained in escrow for release in two years. The full analyst notes on Halma are available to download free of charge at:

http://earnings-review.com/3475-HLMA-09Jun2014.pdf

--
Britvic Plc Analyst Notes
On May 21, 2014, Britvic Plc (Britvic) released its H1 FY 2014 financial results (28 weeks ended April 13, 2014). The Company reported H1 FY 2014 revenue of £670.7 million, up 4.9% YoY. During H1 FY 2014, the Company's Great Britain revenue improved 5.0% YoY to £452.0 million; and revenue from France improved 8.0% YoY to £127.4 million. The Company's H1 FY 2014 profit attributable to equity shareholders stood at £27.5 million, or 11.2 pence per diluted share, compared to profit of £24.7 million, or 10.1 pence per diluted share, in H1 FY 2013 (period ended April 14, 2013). As on April 13, 2014, the Company's cash and cash equivalents were £44.4 million, compared to cash and cash equivalents of £7.4 million on April 14, 2013. The full analyst notes on Britvic are available to download free of charge at:

http://earnings-review.com/3475-BVIC-09Jun2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] earnings-review.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] earnings-review.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] earnings-review.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Earnings Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Earnings Review in this article or report according to the procedures outlined by Earnings Review. Earnings Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Earnings Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Earnings Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Earnings Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Earnings Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Earnings Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

Earnings-Review.com